192 related articles for article (PubMed ID: 12046641)
1. Phenomenology of and risk factors for new-onset diabetes mellitus and diabetic ketoacidosis associated with atypical antipsychotics: an analysis of 45 published cases.
Jin H; Meyer JM; Jeste DV
Ann Clin Psychiatry; 2002 Mar; 14(1):59-64. PubMed ID: 12046641
[TBL] [Abstract][Full Text] [Related]
2. Diabetic ketoacidosis associated with antipsychotic drugs: case reports and a review of literature.
Vuk A; Kuzman MR; Baretic M; Osvatic MM
Psychiatr Danub; 2017 Jun; 29(2):121-135. PubMed ID: 28636569
[TBL] [Abstract][Full Text] [Related]
3. Diabetic ketoacidosis in patients exposed to antipsychotics: a systematic literature review and analysis of Danish adverse drug event reports.
Polcwiartek C; Vang T; Bruhn CH; Hashemi N; Rosenzweig M; Nielsen J
Psychopharmacology (Berl); 2016 Oct; 233(21-22):3663-3672. PubMed ID: 27592232
[TBL] [Abstract][Full Text] [Related]
4. Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review.
Newcomer JW
CNS Drugs; 2005; 19 Suppl 1():1-93. PubMed ID: 15998156
[TBL] [Abstract][Full Text] [Related]
5. Rapid onset of quetiapine-induced diabetic ketoacidosis in an elderly patient: a case report.
Takahashi M; Ohishi S; Katsumi C; Moriya T; Miyaoka H
Pharmacopsychiatry; 2005 Jul; 38(4):183-4. PubMed ID: 16025424
[TBL] [Abstract][Full Text] [Related]
6. Risk of diabetic ketoacidosis after exposure to risperidone or olanzapine.
Ramaswamy K; Kozma CM; Nasrallah H
Drug Saf; 2007; 30(7):589-99. PubMed ID: 17604410
[TBL] [Abstract][Full Text] [Related]
7. Do certain atypical antipsychotics increase the risk of diabetes? A critical review of 17 pharmacoepidemiologic studies.
Ramaswamy K; Masand PS; Nasrallah HA
Ann Clin Psychiatry; 2006; 18(3):183-94. PubMed ID: 16923657
[TBL] [Abstract][Full Text] [Related]
8. Hyperglycemia and antipsychotic medications.
Haupt DW; Newcomer JW
J Clin Psychiatry; 2001; 62 Suppl 27():15-26; discussion 40-1. PubMed ID: 11806485
[TBL] [Abstract][Full Text] [Related]
9. New-onset diabetes and ketoacidosis with atypical antipsychotics.
Wilson DR; D'Souza L; Sarkar N; Newton M; Hammond C
Schizophr Res; 2003 Jan; 59(1):1-6. PubMed ID: 12413635
[TBL] [Abstract][Full Text] [Related]
10. Clinical experience with insulin resistance, diabetic ketoacidosis, and type 2 diabetes mellitus in patients treated with atypical antipsychotic agents.
Henderson DC
J Clin Psychiatry; 2001; 62 Suppl 27():10-4; discussion 40-1. PubMed ID: 11806484
[TBL] [Abstract][Full Text] [Related]
11. Atypical antipsychotics and new onset diabetes mellitus. An overview of the literature.
Cohen D
Pharmacopsychiatry; 2004 Jan; 37(1):1-11. PubMed ID: 14750042
[TBL] [Abstract][Full Text] [Related]
12. Comparative safety of antipsychotics: another look at the risk of diabetes.
Moisan J; Turgeon M; Desjardins O; Grégoire JP
Can J Psychiatry; 2013 Apr; 58(4):218-24. PubMed ID: 23547645
[TBL] [Abstract][Full Text] [Related]
13. Atypical antipsychotics and diabetic ketoacidosis: a review.
Guenette MD; Hahn M; Cohn TA; Teo C; Remington GJ
Psychopharmacology (Berl); 2013 Mar; 226(1):1-12. PubMed ID: 23344556
[TBL] [Abstract][Full Text] [Related]
14. Fatal diabetic ketoacidosis and antipsychotic medication.
Ely SF; Neitzel AR; Gill JR
J Forensic Sci; 2013 Mar; 58(2):398-403. PubMed ID: 23278567
[TBL] [Abstract][Full Text] [Related]
15. Using antipsychotic agents in older patients.
Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
[TBL] [Abstract][Full Text] [Related]
16. Diabetic ketoacidosis associated with aripiprazole.
Makhzoumi ZH; McLean LP; Lee JH; Ibe AI
Pharmacotherapy; 2008 Sep; 28(9):1198-202. PubMed ID: 18752391
[TBL] [Abstract][Full Text] [Related]
17. Olanzapine-induced diabetic ketoacidosis.
Ragucci KR; Wells BJ
Ann Pharmacother; 2001 Dec; 35(12):1556-8. PubMed ID: 11793618
[TBL] [Abstract][Full Text] [Related]
18. Elevated hemoglobin A1c as a possible indicator of diabetes mellitus and diabetic ketoacidosis in schizophrenia patients receiving atypical antipsychotics.
Henderson DC; Cagliero E; Copeland PM; Louie PM; Borba CP; Fan X; Freudenreich O; Goff DC
J Clin Psychiatry; 2007 Apr; 68(4):533-41. PubMed ID: 17474808
[TBL] [Abstract][Full Text] [Related]
19. Factors in antipsychotic drug selection: tolerability considerations.
Nasrallah HA
CNS Spectr; 2003 Nov; 8(11 Suppl 2):23-5. PubMed ID: 14978455
[TBL] [Abstract][Full Text] [Related]
20. Rate of new-onset diabetes among patients treated with atypical or conventional antipsychotic medications for schizophrenia.
Ollendorf DA; Joyce AT; Rucker M
MedGenMed; 2004 Jan; 6(1):5. PubMed ID: 15208518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]